Načítá se...

The discovery and development of belimumab: the anti-BLyS–lupus connection

For the first time in more than 50 years, the US Food and Drug Administration has approved a drug specifically for the treatment of systemic lupus erythematosus (SLE). This drug, belimumab (Benlysta), is a human monoclonal antibody that neutralizes the B-cell survival factor, B-lymphocyte stimulator...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Stohl, William, Hilbert, David M
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3264947/
https://ncbi.nlm.nih.gov/pubmed/22231104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.2076
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!